Skip to main content
Clinical Trials/CTRI/2014/11/005229
CTRI/2014/11/005229
Recruiting
Phase 2

An assessment of the effect of preoperative hydroxyprogesterone on serial levels of circulating tumour cells and serum nucleic acids (DNA and chromatin) in patients undergoing surgery for operable breast cancer.

Tata Memorial Centre0 sites100 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tata Memorial Centre
Enrollment
100
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Breast cancer patients with loco\-regionally confined disease planned for up front surgery shall be taken into the study. FNAC or core biopsy proven breast cancer with clinically positive axillary nodes T1\-3 N1 patients will be eligible

Exclusion Criteria

  • 1\.Prior excision biopsy
  • 2\.Patients receiving preoperative chemotherapy
  • 3\.Prior treatment for any other malignancies
  • 4\.Women who are pregnant, breast\-feeding.

Outcomes

Primary Outcomes

Not specified

Similar Trials